Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Group B Streptococcus (GBS) surface protein antigens are a collection of proteins expressed on the bacterial cell surface that contribute to virulence, immune evasion, and host-pathogen interactions. Key examples include β Protein (involved in complement evasion), BspC (promoting brain endothelium adhesion), BPS Protein (eliciting protective immunity), Alpha C Protein Family (mediating adhesion/invasion), and C5a Peptidase (disrupting neutrophil recruitment). These proteins are potential targets for vaccine development and diagnostic assays, and are involved in various functions such as adherence to host cells, invasion into epithelial barriers, binding host immune regulators, and inducing inflammatory responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Group B Streptococcus Surface Protein Antigens (GBS Surface Proteins).